147 related articles for article (PubMed ID: 10699717)
21. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method.
Lin W; Coombes AG; Davies MC; Davis SS; Illum L
J Drug Target; 1993; 1(3):237-43. PubMed ID: 8069565
[TBL] [Abstract][Full Text] [Related]
22. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups.
Weber C; Reiss S; Langer K
Int J Pharm; 2000 Dec; 211(1-2):67-78. PubMed ID: 11137340
[TBL] [Abstract][Full Text] [Related]
23. Robust size control of bovine serum albumin (BSA) nanoparticles by intermittent addition of a desolvating agent and the particle formation mechanism.
Paik SY; Nguyen HH; Ryu J; Che JH; Kang TS; Lee JK; Song CW; Ko S
Food Chem; 2013 Nov; 141(2):695-701. PubMed ID: 23790836
[TBL] [Abstract][Full Text] [Related]
24. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
25. The Effects of Organic Solvents on the Physicochemical Properties of Human Serum Albumin Nanoparticles.
Mohammad-Beigi H; Shojaosadati SA; Morshedi D; Mirzazadeh N; Arpanaei A
Iran J Biotechnol; 2016 Mar; 14(1):45-50. PubMed ID: 28959317
[TBL] [Abstract][Full Text] [Related]
26. PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent.
Fahrländer E; Schelhaas S; Jacobs AH; Langer K
Nanotechnology; 2015 Apr; 26(14):145103. PubMed ID: 25789544
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial releasing titanium surface using albumin nanoparticle carriers.
Kim DH; Kim KH; Kwon TY; Choi SH; Kang SS; Kwon ST; Cho DH; Kim HD; Son JS
J Nanosci Nanotechnol; 2014 Nov; 14(11):8422-6. PubMed ID: 25958539
[TBL] [Abstract][Full Text] [Related]
29. Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line.
Fallacara AL; Mancini A; Zamperini C; Dreassi E; Marianelli S; Chiariello M; Pozzi G; Santoro F; Botta M; Schenone S
Bioorg Med Chem Lett; 2017 Jul; 27(14):3196-3200. PubMed ID: 28558969
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
[TBL] [Abstract][Full Text] [Related]
31. Human Serum Albumin Nanoparticles as a Novel Delivery System for Cabazitaxel.
Zhou G; Jin X; Zhu P; Yao JU; Zhang Y; Teng L; Lee RJ; Zhang X; Hong W
Anticancer Res; 2016 Apr; 36(4):1649-56. PubMed ID: 27069142
[TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Jiang S; Gong X; Zhao X; Zu Y
Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
[TBL] [Abstract][Full Text] [Related]
33. Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene.
Mo Y; Barnett ME; Takemoto D; Davidson H; Kompella UB
Mol Vis; 2007 May; 13():746-57. PubMed ID: 17563725
[TBL] [Abstract][Full Text] [Related]
34. Human serum albumin (HSA) nanoparticles stabilized with intermolecular disulfide bonds.
Wang W; Huang Y; Zhao S; Shao T; Cheng Y
Chem Commun (Camb); 2013 Mar; 49(22):2234-6. PubMed ID: 23396533
[TBL] [Abstract][Full Text] [Related]
35. Preparation and in vitro investigation of antigastric cancer activities of carvacrol-loaded human serum albumin nanoparticles.
Maryam K; Shakeri S; Kiani K
IET Nanobiotechnol; 2015 Oct; 9(5):294-9. PubMed ID: 26435283
[TBL] [Abstract][Full Text] [Related]
36. Preparation of soluble stable C₆₀/human serum albumin nanoparticles via cyclodextrin complexation and their reactive oxygen production characteristics.
Abdulmalik A; Hibah A; Zainy BM; Makoto A; Daisuke I; Masaki O; Kaneto U; Fumitoshi H
Life Sci; 2013 Aug; 93(7):277-82. PubMed ID: 23850514
[TBL] [Abstract][Full Text] [Related]
37. Effects of preparation conditions on the monodispersity of albumin microspheres.
el-Mahdy M; Ibrahim ES; Safwat S; el-Sayed A; Ohshima H; Makino K; Muramatsu N; Kondo T
J Microencapsul; 1998; 15(5):661-73. PubMed ID: 9743920
[TBL] [Abstract][Full Text] [Related]
38. Effect of cross-linker glutaraldehyde on gastric digestion of emulsified albumin.
Del Castillo-Santaella T; Maldonado-Valderrama J; Molina-Bolivar JA; Galisteo-Gonzalez F
Colloids Surf B Biointerfaces; 2016 Sep; 145():899-905. PubMed ID: 27341303
[TBL] [Abstract][Full Text] [Related]
39. The role of surface charge in the desolvation process of gelatin: implications in nanoparticle synthesis and modulation of drug release.
Ahsan SM; Rao CM
Int J Nanomedicine; 2017; 12():795-808. PubMed ID: 28182126
[TBL] [Abstract][Full Text] [Related]
40. Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles.
Kumar PV; Jain NK
AAPS PharmSciTech; 2007 Mar; 8(1):17. PubMed ID: 17408217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
